BCA
SBBP

Berman Capital Advisors’s Strongbridge Biopharma plc. SBBP Stock Holding History

Berman Capital Advisors’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-360
Closed – – 1968
2020
Q4 		$0 Hold
360
– – ﹤0.01% 1895
2020
Q3 		$0 Sell
360
-497
-58% -$1.68K ﹤0.01% 1852
2020
Q2 		$3K Buy
+857
New +$2.57K ﹤0.01% 1210

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Berman Capital Advisors's SBBP Position: Q1 2021 in Review

Berman Capital Advisors sold out of Strongbridge Biopharma plc. (SBBP) in Q1 2021, closing a stake of 360 shares.

Berman Capital Advisors first reported a position in SBBP in Q2 2020 and held it in 3 quarters. The position peaked at $3K in Q2 2020. 74 funds tracked by Wall St. Rank hold SBBP as of Q1 2021.

  • Berman Capital Advisors reported no remaining Strongbridge Biopharma plc. position as of Q1 2021 after selling out during the quarter.
  • Berman Capital Advisors sold 360 Strongbridge Biopharma plc. shares in Q1 2021.
  • Berman Capital Advisors first reported a position in Strongbridge Biopharma plc. in Q2 2020 and held it in 3 quarters.
  • Berman Capital Advisors's Strongbridge Biopharma plc. position peaked at $3K in Q2 2020.
  • 74 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q1 2021.

Based on Berman Capital Advisors's 13F filing for Q1 2021, filed 11 May 2021.